Skip to main content
Premium Trial:

Request an Annual Quote

SGX Grants Lilly Access to Its Beamline

NEW YORK, Jan. 15 (GenomeWeb News) - Structural Genomix said today it will provide Eli Lilly with long-term access to the SGX synchrotron beamline facility at the Advanced Photon Source at Argonne National Laboratory in Chicago.

 

SGX, of San Diego, Calif., will generate x-ray crystallography data on drug targets and compounds provided by Lilly. In return, Lilly will pay SGX an upfront access fee and an annual fee to cover operating costs. Lilly also has the option to expand its access to the beamline in the future for additional payments.

 

SGX has been providing Lilly with its high-throughput protein crystallography technology since last April.

 

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.